Skip to content
engulfing.
EN Sign in Get started
News / Headline

Johnson & Johnson Looking To Buy Eye Disease Biotech For Up To $3.4B

UTC · Financial Times

Make engulfing yours

Choose your language, markets and timezone independently.

Markets to follow
Major global events remain included. Clear all markets for a global view.

Remembered on this device. Sign in to sync with your account.

IP Geolocation by DB-IP